← All organizations

Nordic Society for Gynaecologic Oncology

Academic/HospitalWebsite ↗

Also known as: Nordic Society for Gynaecologic Oncology | NSGO | NSGO-CTU

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Sep 30, 2023

Timeline

1980s

Nov 1, 1986
Nordic Society for Gynaecologic Oncology— Founded

Drugs by trial phase (23 distinct, 17 trials)

Phase 3 (11 own, 0 via acquisition)

Phase 2 (12 own, 0 via acquisition)

Indications

Studied for

Recent trials (20)

NCT05201001Study chairPhase 2Sep 30, 2023
NCT03806049Study chairPhase 3Jun 30, 2019
NCT03806049Lead sponsorPhase 3Jun 30, 2019
NCT03795272Lead sponsorPhase 2Mar 1, 2019
NCT03267589Lead sponsorPhase 2Mar 16, 2018
NCT02730429Lead sponsorPhase 2Feb 15, 2017
NCT02730416Lead sponsorPhase 2Nov 1, 2016
NCT02477644CollaboratorPhase 3May 1, 2015
NCT02866370CollaboratorPhase 2Apr 1, 2015
NCT02354131Lead sponsorPhase 1/Phase 2Feb 1, 2015
NCT02354131Study chairPhase 1/Phase 2Feb 1, 2015
NCT01244789CollaboratorPhase 3Dec 1, 2011
NCT01462890CollaboratorPhase 3Nov 1, 2011
NCT02026921Study chairPhase 2Jun 1, 2004
NCT02026921Lead sponsorPhase 2Jun 1, 2004

Details

Founded: Oslo, NO Nov 1, 1986
Last known activity: Sep 30, 2023